PATENT CLAIM ANALYSIS

Application Number: 16161926
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["544", "333000"]

Abstract:
Disclosed are benzamide derivatives useful in slowing the expansion of cancer cells.

Claim (Index 33):
The compound of  claim 32 , wherein Q is H.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14733952', '13380213', '13813813', '12295967', '10719896']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7691496165451372
- 35 USC 102 Novelty (BERT): 0.506252162538607
- Combined Prediction Score: 0.7428598711444843
- Mean Citation Score: 201.57804600000003
- Max Citation Score: 229.9136
- Similarity Product: 137.5843949661255

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test